Literature DB >> 21357624

Methods for peptide and protein quantitation by liquid chromatography-multiple reaction monitoring mass spectrometry.

Haixia Zhang1, Qinfeng Liu, Lisa J Zimmerman, Amy-Joan L Ham, Robbert J C Slebos, Jamshedur Rahman, Takefume Kikuchi, Pierre P Massion, David P Carbone, Dean Billheimer, Daniel C Liebler.   

Abstract

Liquid chromatography-multiple reaction monitoring mass spectrometry of peptides using stable isotope dilution (SID) provides a powerful tool for targeted protein quantitation. However, the high cost of labeled peptide standards for SID poses an obstacle to multiple reaction monitoring studies. We compared SID to a labeled reference peptide (LRP) method, which uses a single labeled peptide as a reference standard for all measured peptides, and a label-free (LF) approach, in which quantitation is based on analysis of un-normalized peak areas for detected MRM transitions. We analyzed peptides from the Escherichia coli proteins alkaline phosphatase and β-galactosidase spiked into lysates from human colon adenocarcinoma RKO cells. We also analyzed liquid chromatography-multiple reaction monitoring mass spectrometry data from a recently published interlaboratory study by the National Cancer Institute Clinical Proteomic Technology Assessment for Cancer network (Addona et al. (2009) Nat. Biotechnol. 27: 633-641), in which unlabeled and isotopically labeled synthetic peptides or their corresponding proteins were spiked into human plasma. SID displayed the highest correlation coefficients and lowest coefficient of variation in regression analyses of both peptide and protein spike studies. In protein spike experiments, median coefficient of variation values were about 10% for SID and 20-30% for LRP and LF methods. Power calculations indicated that differences in measurement error between the methods have much less impact on measured protein expression differences than biological variation. All three methods detected significant (p < 0.05) differential expression of three endogenous proteins in a test set of 10 pairs of human lung tumor and control tissues. Further, the LRP and LF methods both detected significant differences (p < 0.05) in levels of seven biomarker candidates between tumors and controls in the same set of lung tissue samples. The data indicate that the LRP and LF methods provide cost-effective alternatives to SID for many quantitative liquid chromatography-multiple reaction monitoring mass spectrometry applications.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21357624      PMCID: PMC3108838          DOI: 10.1074/mcp.M110.006593

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  44 in total

1.  The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications.

Authors:  Donald S Kirkpatrick; Scott A Gerber; Steven P Gygi
Journal:  Methods       Date:  2005-01-12       Impact factor: 3.608

Review 2.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility.

Authors:  Nader Rifai; Michael A Gillette; Steven A Carr
Journal:  Nat Biotechnol       Date:  2006-08       Impact factor: 54.908

3.  Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma.

Authors:  Michael A Kuzyk; Derek Smith; Juncong Yang; Tyra J Cross; Angela M Jackson; Darryl B Hardie; N Leigh Anderson; Christoph H Borchers
Journal:  Mol Cell Proteomics       Date:  2009-05-01       Impact factor: 5.911

4.  Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.

Authors:  Terri A Addona; Susan E Abbatiello; Birgit Schilling; Steven J Skates; D R Mani; David M Bunk; Clifford H Spiegelman; Lisa J Zimmerman; Amy-Joan L Ham; Hasmik Keshishian; Steven C Hall; Simon Allen; Ronald K Blackman; Christoph H Borchers; Charles Buck; Helene L Cardasis; Michael P Cusack; Nathan G Dodder; Bradford W Gibson; Jason M Held; Tara Hiltke; Angela Jackson; Eric B Johansen; Christopher R Kinsinger; Jing Li; Mehdi Mesri; Thomas A Neubert; Richard K Niles; Trenton C Pulsipher; David Ransohoff; Henry Rodriguez; Paul A Rudnick; Derek Smith; David L Tabb; Tony J Tegeler; Asokan M Variyath; Lorenzo J Vega-Montoto; Asa Wahlander; Sofia Waldemarson; Mu Wang; Jeffrey R Whiteaker; Lei Zhao; N Leigh Anderson; Susan J Fisher; Daniel C Liebler; Amanda G Paulovich; Fred E Regnier; Paul Tempst; Steven A Carr
Journal:  Nat Biotechnol       Date:  2009-06-28       Impact factor: 54.908

5.  Endogenous secretory receptor for advanced glycation end products in non-small cell lung carcinoma.

Authors:  Seiichi Kobayashi; Hiroshi Kubo; Takashi Suzuki; Kota Ishizawa; Mitsuhiro Yamada; Mei He; Yasuhiko Yamamoto; Hiroshi Yamamoto; Hironobu Sasano; Hidetada Sasaki; Satoshi Suzuki
Journal:  Am J Respir Crit Care Med       Date:  2006-10-05       Impact factor: 21.405

6.  DJ-1, a novel regulator of the tumor suppressor PTEN.

Authors:  Raymond H Kim; Malte Peters; YingJu Jang; Wei Shi; Melania Pintilie; Graham C Fletcher; Carmela DeLuca; Jennifer Liepa; Lily Zhou; Bryan Snow; Richard C Binari; Armen S Manoukian; Mark R Bray; Fei-Fei Liu; Ming-Sound Tsao; Tak W Mak
Journal:  Cancer Cell       Date:  2005-03       Impact factor: 31.743

7.  Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics.

Authors:  Paola Picotti; Bernd Bodenmiller; Lukas N Mueller; Bruno Domon; Ruedi Aebersold
Journal:  Cell       Date:  2009-08-06       Impact factor: 41.582

8.  Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution.

Authors:  Hasmik Keshishian; Terri Addona; Michael Burgess; D R Mani; Xu Shi; Eric Kuhn; Marc S Sabatine; Robert E Gerszten; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2009-07-13       Impact factor: 5.911

9.  Simultaneous determination of ABT-888, a poly (ADP-ribose) polymerase inhibitor, and its metabolite in human plasma by liquid chromatography/tandem mass spectrometry.

Authors:  Richard Wiegand; Jianmei Wu; Xianyi Sha; Patricia LoRusso; Jing Li
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-11-27       Impact factor: 3.205

10.  Simultaneous determination of levetiracetam and its acid metabolite (ucb L057) in serum/plasma by liquid chromatography tandem mass spectrometry.

Authors:  Damodara Rao Mendu; Steven J Soldin
Journal:  Clin Biochem       Date:  2009-11-23       Impact factor: 3.281

View more
  47 in total

Review 1.  Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions.

Authors:  Paola Picotti; Ruedi Aebersold
Journal:  Nat Methods       Date:  2012-05-30       Impact factor: 28.547

2.  Targeted Quantitative Proteomic Approach for High-Throughput Quantitative Profiling of Small GTPases in Brain Tissues of Alzheimer's Disease Patients.

Authors:  Ming Huang; Martin Darvas; C Dirk Keene; Yinsheng Wang
Journal:  Anal Chem       Date:  2019-09-10       Impact factor: 6.986

3.  Chronic nicotine treatment impacts the regulation of opioid and non-opioid peptides in the rat dorsal striatum.

Authors:  Filomena Petruzziello; Sara Falasca; Per E Andren; Gregor Rainer; Xiaozhe Zhang
Journal:  Mol Cell Proteomics       Date:  2013-02-22       Impact factor: 5.911

4.  Proteomic analysis of oropharyngeal carcinomas reveals novel HPV-associated biological pathways.

Authors:  Robbert J C Slebos; Nico Jehmlich; Brandee Brown; Zhirong Yin; Christine H Chung; Wendell G Yarbrough; Daniel C Liebler
Journal:  Int J Cancer       Date:  2012-07-20       Impact factor: 7.396

5.  Evaluating kinase ATP uptake and tyrosine phosphorylation using multiplexed quantification of chemically labeled and post-translationally modified peptides.

Authors:  Bin Fang; Melissa A Hoffman; Abu-Sayeef Mirza; Katie M Mishall; Jiannong Li; Scott M Peterman; Keiran S M Smalley; Kenneth H Shain; Paul M Weinberger; Jie Wu; Uwe Rix; Eric B Haura; John M Koomen
Journal:  Methods       Date:  2015-03-14       Impact factor: 3.608

6.  Selected reaction monitoring approach for validating peptide biomarkers.

Authors:  Qing Wang; Ming Zhang; Tyler Tomita; Joshua T Vogelstein; Shibin Zhou; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-04       Impact factor: 11.205

Review 7.  The Skyline ecosystem: Informatics for quantitative mass spectrometry proteomics.

Authors:  Lindsay K Pino; Brian C Searle; James G Bollinger; Brook Nunn; Brendan MacLean; Michael J MacCoss
Journal:  Mass Spectrom Rev       Date:  2017-07-09       Impact factor: 10.946

8.  Protein biomarkers of new-onset cardiovascular disease: prospective study from the systems approach to biomarker research in cardiovascular disease initiative.

Authors:  Xiaoyan Yin; Subha Subramanian; Shih-Jen Hwang; Christopher J O'Donnell; Caroline S Fox; Paul Courchesne; Pieter Muntendam; Neal Gordon; Aram Adourian; Peter Juhasz; Martin G Larson; Daniel Levy
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-13       Impact factor: 8.311

9.  Oncogenic KRAS and BRAF Drive Metabolic Reprogramming in Colorectal Cancer.

Authors:  Josiah E Hutton; Xiaojing Wang; Lisa J Zimmerman; Robbert J C Slebos; Irina A Trenary; Jamey D Young; Ming Li; Daniel C Liebler
Journal:  Mol Cell Proteomics       Date:  2016-06-23       Impact factor: 5.911

10.  Mass spectrometry assessment of ubiquitin carboxyl-terminal hydrolase L1 partitioning between soluble and particulate brain homogenate fractions.

Authors:  Junjun Chen; Richard Y-C Huang; Illarion V Turko
Journal:  Anal Chem       Date:  2013-06-06       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.